Contents
Excluded laboratory owner Medicare fraud centers on who actually runs the lab and whose work Medicare pays for. The enrollment form may name a spouse while someone else hires staff, negotiates with treatment providers and directs the business. Taxpayers pay while the person directing the business stays off the paperwork. Inside the laboratory, those decisions leave a trail. The employee taking instructions may know far more about who runs the operation than the name on the application reveals.
Federal health care programs cannot pay for items or services furnished, ordered or prescribed by an excluded person or entity. The HHS Office of Inspector General’s exclusion guidance also puts hiring in view: an organization that hires someone on its exclusion list may face civil monetary penalties. The Inspector General’s office calls for routine checks of new hires and current employees.
That makes the person’s work important alongside the company’s billing identity. An exclusion record identifies the person and the period at issue. Employment records and operating instructions show what that person continued to do. Claims and payments show where the government money went. We examine those connections together.
The staffing issue also appears in administrative settlements. The Inspector General’s laboratory enforcement entries include Physicians Immunodiagnostic Laboratory’s settlement in 2014 over allegedly employing an excluded individual. American Esoteric Laboratories settled an excluded-employee matter in 2013.
When an excluded laboratory owner operates through spouse company enrollment, the question is who really runs the business after the paperwork names someone else. Hiring, negotiations, management work and compensation can show the working relationship behind the application.
American Toxicology Labs illustrates that split. In its June 2020 announcement of the operator’s and his wife’s guilty pleas, the Justice Department described a laboratory established in Johnson City, Tennessee, in May 2013. The husband had already been excluded from federal health care programs in June 2012, the year before the laboratory opened. The wife appeared as owner on the Medicare and Medicaid applications. Her husband’s name and participation were omitted.
According to that criminal plea announcement, the laboratory conducted urine screens for entities presenting themselves as opioid treatment facilities. The husband made employment decisions, negotiated business arrangements with providers and participated in management.
Medicare and state Medicaid programs paid the laboratory approximately $8.5 million between May 2014 and January 2020, according to the same announcement.
For someone who dealt with the lab, the revealing detail could have been ordinary business: who negotiated the arrangement, who made a hiring decision, who gave the next instruction. Those are the decisions the government’s account followed.
The government’s complaint involving Tomoka Medical Lab describes another separation between the ownership names and the person directing operations. It alleges that, after Medicare suspended payments to Tomoka and Tennessee Valley Regional Laboratory in August 2020, their owner formed United Diagnostics and named his spouse and children as owners.
The complaint goes beyond the family relationship. It alleges that he remained a managing partner overseeing operations, sales and marketing. According to the complaint, his wife held the majority ownership but received no income from the company he helped run. The government also alleged that United Diagnostics used the same provider identifier as Golden Rule Management, served the same laboratories and collection sites, and provided staffing.
The alleged continuity reached the accounts. According to the complaint, the managing partner used United Diagnostics’ bank accounts to pay himself and family members, laboratory payroll, employee benefits and leases for laboratories and collection sites.
The government’s Tomoka complaint alleges that the same owner who managed the family-held United Diagnostics instructed the operations manager to enter molecular-panel codes for standard urinalysis orders and told her he had programmed diagnoses into claims that the treating physicians had not supplied.
Evidence of excluded laboratory owner fraud connects the person’s status and actual work to specific government claims. We work out with you which records carry that connection, from the enrollment application to the instructions inside the lab and the claims sent for payment.
Different employees encounter different parts of that chain. A billing worker may see the diagnosis or test code entered after the physician’s order arrives. An operations manager may hear the instruction that explains the change. Someone handling payroll may see which company pays the people working at the laboratory and who authorizes those payments. The Tomoka allegations join those ordinary records into one account of the business.
The industry’s compliance literature has long treated staffing and management as part of the problem. Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, described the Inspector General’s voluntary model plan. It connected policies on retaining sanctioned individuals with a compliance officer responsible for maintaining and monitoring the laboratory’s policies.
That history gives an employee’s account more context. The written policy, the people assigned to enforce it and management’s response to an objection can be compared with the work that continued. We work through that comparison with the person who saw it.
The Centers for Medicare & Medicaid Services compares laboratory billing with whether a working laboratory exists. In an August 2026 laboratory enforcement announcement, the agency described a consulting-company owner who enrolled 14 laboratories and billed more than $24 million for services. CMS said none of the laboratories was operational.
The agency also described using claims analytics to flag unusual testing, billing, documentation and relationships, with claims held, rejected or denied before payment where appropriate.
A worker can supply the operational detail behind a billing pattern: who was present, what equipment was available, where samples went and who directed the claims. We connect that account to the relevant enrollment, work and payment records.
A laboratory whistleblower case connects what someone inside the business knows to false claims involving government money. The Tomoka case began with an operations manager’s account, and the government joined it, filing its own complaint. Her knowledge reached both the instructions inside the lab and the claims sent outside it.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We build the case with you around who did the work, what the lab told Medicare or Medicaid, and what the programs paid.
If you know whose instructions the lab follows while its paperwork names someone else, speak with our whistleblower experts about the people and claims behind that billing number. We build the case with you and bring in laboratory fraud whistleblower lawyers who understand concealed ownership, testing orders and government billing. We stay with you through the process, pressing the connection between hidden control and paid claims to build your strongest whistleblower case.